Gabriela Anahi Rozic
Rosh Hayin
Summary
PhD-trained translational scientist and R&D leader with an MBA in Big Data and Business Intelligence, specializing in neurobiology, translational oncology, and precision medicine. Proven ability to spearhead preclinical and translational research initiatives by integrating data, advanced functional models, and clinical insights to inform data-driven decisions that significantly improve patient outcomes. Expertise in assay development, preclinical candidate evaluation, and early development support emphasizes a results-oriented approach focused on leadership and organizational success. Recognized for fostering team collaboration and consistently delivering high-quality results while navigating evolving challenges through strategic decision-making and conflict resolution.
Overview
15
15
years of professional experience
Work History
R&D Scientific Leader. Translational Oncology & Personalized Medicine
Institute for Personalized and Translational Medicine, Ariel University
07.2021 - 03.2026
- Directed translational research strategy and execution, integrating biological insights with computational analysis and clinical data.
- Led development of innovative personalized platforms for drug response prediction to enhance responder population identification and patient stratification.
- Managed the design and implementation of mechanistic assays and high-content screening processes, guaranteeing consistent results and reliable data.
- Directed data analysis, interpretation, and communication of complex datasets.
- Directed project timelines and resource allocation to ensure timely delivery of project milestones while fostering teamwork.
- Collaborated on intellectual property initiatives and authored publications that reflect scientific excellence and practical application.
- Facilitated knowledge transfer to junior staff on effective personalized medicine strategies and data analysis techniques.
- Evaluated data trends to guide strategic decisions on research initiatives.
- Identified areas of improvement within the team and implemented strategies to address concerns effectively.
R&D Scientific Leader. Drug Development
Institute for Personalized and Translational Medicine, Ariel University
01.2017 - 01.2020
- Led preclinical development initiatives for novel cancer therapeutics to enhance hit-to-lead optimization and facilitate translational evaluation.
- Developed and implemented comprehensive assays to evaluate drug mechanism efficacy and safety, ensuring robust experimental protocols.
- Performed in vivo studies focused on candidate evaluation, synthesizing results to enhance translational medicine strategies.
- Facilitated collaboration with CROs, ensuring strategic alignment with translational and clinical objectives.
- Contributed to intellectual property development by managing patent filings and publications, supporting advancement of scientific and translational initiatives.
- Supervised daily functions of staff in establishment, fostering a positive atmosphere aimed at improving employee engagement and experiences.
- Administered budgets and resources, ensuring effective allocation to drive achievement of organizational targets.
R&D Project Leader. Multiple Myeloma Translational Research
Sheba Medical Center
01.2013 - 01.2017
- Oversaw research projects aimed at advancing treatment of hematological malignancies.
- Conducted identification and evaluation of innovative therapeutic strategies, including drug response studies, leading to patents and peer-reviewed publications.
- Analyzed and interpreted proteomic and mechanistic data, effectively communicating findings to elucidate drug mechanisms and their impact on pathways.
- Facilitated collaborative research initiatives with industry partners to explore cannabinoid-based therapeutic applications.
- Designed and performed rigorous in vivo and in vitro assays, supporting translational development and enhancing preclinical candidate evaluation.
R&D Research Assistant. Oncology
Beilinson Medical Center
01.2011 - 01.2012
- Executed in vitro and in vivo therapeutic evaluation studies to advance preclinical oncology research efforts.
- Analyzed relevant literature to provide critical insights for advancing clinical research projects.
- Facilitated collaboration among member teams to implement robust research protocols.
- Collaborated in drafting grant proposals aimed at obtaining financial support for research projects.
- Contributed to the publication of research articles in peer-reviewed journals, showcasing expertise in various topics.
Education
MBA - Big Data & Business Intelligence
Tel Aviv University
Tel Aviv02-2020
Postdoctoral Fellowship - Molecular Neurobiology
Tel Aviv University
Israel01-2011
Ph.D. - Molecular Neurobiology
Tel Aviv University
Israel01-2008
M.Sc. (Honors) - Immunology
Tel Aviv University
Israel01-2002
B.Sc. - Clinical Diagnostics And Biochemistry
South National University
Argentina01-1997
Skills
- Effective team leadership
- Strategic planning
- Problem-solving skills
- Collaborative teamwork
- Efficient task management
- Strong communication
Languages
Spanish
Native or Bilingual
English
Full Professional
Hebrew
Native or Bilingual
Timeline
R&D Scientific Leader. Translational Oncology & Personalized Medicine
Institute for Personalized and Translational Medicine, Ariel University
07.2021 - 03.2026
R&D Scientific Leader. Drug Development
Institute for Personalized and Translational Medicine, Ariel University
01.2017 - 01.2020
R&D Project Leader. Multiple Myeloma Translational Research
Sheba Medical Center
01.2013 - 01.2017
R&D Research Assistant. Oncology
Beilinson Medical Center
01.2011 - 01.2012
MBA - Big Data & Business Intelligence
Tel Aviv University
Postdoctoral Fellowship - Molecular Neurobiology
Tel Aviv University
Ph.D. - Molecular Neurobiology
Tel Aviv University
M.Sc. (Honors) - Immunology
Tel Aviv University
B.Sc. - Clinical Diagnostics And Biochemistry
South National University
Selected Competitive Fundings
- Bioprinted Assembloids for Tumor-Infiltrating Lymphocytes’ (TILs) Theragnostics in dMMR/MSI-High Colorectal Cancer and Other GI Malignancies. Ministry of Innovation, Science and Technology, 2025-2028.
- Development of a Novel Tumor Avatar Platform for Precision Oncology, Ariel University, 2023.
- Implementation of a novel Tumor avatar model as a Precision Oncology and Drug Development Platform. Entrepreneurship Booster Program. Ariel University, 2023.
- Deep Neuron Measurements and Data Analysis. Interdisciplinary Internal Grant, Ariel University, 2019.
- Development of an Ex-Vivo System for Precision Oncology. Institute for Personalized and Translational Medicine, Ariel University, 2021-2025.